Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort Study

Blood - United States
doi 10.1182/blood.v116.21.807.807
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Hematology

Related search

Hematocrit and the Risk of Recurrent Venous Thrombosis: A Prospective Cohort Study

PLoS ONE
Multidisciplinary
2012English

Mild Antithrombin Deficiency and Risk of Recurrent Venous Thromboembolism: A Prospective Cohort Study

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

Statin Therapy and Recurrent Venous Thromboembolism in the Elderly: A Prospective Cohort Study

Scientific Reports
Multidisciplinary
2019English

Hematocrit and Risk of Venous Thromboembolism in a General Population. The Tromso Study

Haematologica
Hematology
2009English

A Prospective Study of Anticardiolipin Antibodies as a Risk Factor for Venous Thrombosis in a General Population (The HUNT Study)

Journal of Thrombosis and Haemostasis
MedicineHematology
2005English

Antibiotic Use as a Marker of Acute Infection and Risk of First and Recurrent Venous Thrombosis

British Journal of Haematology
Hematology
2017English

Antipsychotics and Risk of Venous Thrombosis

British Journal of Psychiatry
MedicinePsychiatryMental Health
2002English

Lipid Levels and Risk of Venous Thrombosis: Results From the MEGA-study

European Journal of Epidemiology
Epidemiology
2017English

Myocardial Infarction, Prothrombotic Genotypes, and Venous Thrombosis Risk: The Tromsø Study

Research and Practice in Thrombosis and Haemostasis
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy